Detalles de la búsqueda
1.
Safety and immunogenicity of a variant-adapted SARS-CoV-2 recombinant protein vaccine with AS03 adjuvant as a booster in adults primed with authorized vaccines: a phase 3, parallel-group study.
EClinicalMedicine
; 62: 102109, 2023 Aug.
Artículo
en Inglés
| MEDLINE | ID: mdl-37533419
2.
Safety and immunogenicity of an AS03-adjuvanted SARS-CoV-2 recombinant protein vaccine (CoV2 preS dTM) in healthy adults: interim findings from a phase 2, randomised, dose-finding, multicentre study.
Lancet Infect Dis
; 22(5): 636-648, 2022 05.
Artículo
en Inglés
| MEDLINE | ID: mdl-35090638
3.
Review of Lisdexamfetamine Dimesylate in Adults With Attention-Deficit/Hyperactivity Disorder.
J Cent Nerv Syst Dis
; 9: 1179573517728090, 2017.
Artículo
en Inglés
| MEDLINE | ID: mdl-28855799
Resultados
1 -
3
de 3
1
Próxima >
>>